When Feedback PLC (LON:FDBK) started trialling its app for doctors at the Pennine Acute Hospitals NHS Trust in December 2019 it could not predict the opportunity arising from the current coronavirus (COVID-19) pandemic.
Bleepa is a communication tool for healthcare professionals, which allows them to share and discuss medical images and patient cases. It means that chest X-rays and CT scans are more easily accessible for consultants, doctors and nurses both on-site and remotely.
Pennine turned the pilot programme into a roll-out dedicated to COVID-19 cases, while Feedback added new features such as the option to see whether a patient is on ventilation.
Feedback shares rose 12% to 1.05p this week on news that Bleepa will now be used by the Royal Papworth Hospital NHS Foundation Trust as well.
“The launch of Bleepa at Papworth is further evidence of the changing needs of front-line clinicians around their interaction with medical imaging and with colleagues, something that we are uniquely positioned to enable,” said Feedback’s chief executive Tom Oakley.
The med-tech group has applied for a CE mark, which would provide European regulatory sign off for the device. Once this comes through, the plan is to distribute Bleepa across as many hospitals as possible.
Feedback, which specialises imaging software and systems, has made the platform available free of charge during the pandemic. But the firm sees potential even after the crisis is over, as most types of medical specialties use imaging,
Looking at the wider market, the AIM All-Share index rose 2.9% over the past week, outperforming the FTSE 100, which nudged up just 1.9% in that period.
President Energy PLC (LON:PPC) gained 17% to 1.96p after the government of Argentina, where the oiler is focused, decided to set an internal fixed price for the domestic crude market amid oil trading volatility.
Loyalty scheme specialist Universe Group PLC (LON:UNG) jumped 38% to 5.8p after revealing that this year’s pipeline indicated completed revenues of £5mln in the first quarter, with another £16mln expected through recurring contracts.
Modern Water Group PLC (LON:MWG) surged 14% higher to 2.14p after its Microtox LX, used to test water toxicity, won the “Scientific Instrument Excellent New Product” award in a pool of 9,000 candidates.
Up more than 100% in the year to date to 93.2p, Tiziana Life Sciences PLC (LON:TLSA) has become a firm favourite with investors.
Soon they will have further reasons to be cheerful after the drug developer announced plans to spin off its personalised medicines business.
That’s not a bad effort in the current choppy markets – and the fact that the placing and retail subscription will be done at a premium to Thursday’s price suggests there is plenty of demand for the stock. The new funds infusion will be used to ramp up Open Orphan’s coronavirus testing capacity to 3,000 a day.
Equatorial Palm Oil PLC (LON:PAL) dropped 20% to 0.32p after admitting the global lockdown had hit world demand for its products. It also announced the proposed disposal of its half-share in Liberian Palm Developments for a nominal consideration.
Eye-tracking technology developer Seeing Machines PLC (LON:SEE) lost 11% at 2.43p after it made the “difficult but necessary” decision to cut its cost base.